AdisInsight 2022 Year In Review Report

Download the FREE preview version or, fill out the quick form for full access

This new report summarizes the journey of drug development in 2022, providing key takeaways on the potential of new and existing medicines, clinical studies, safety data, key events in the field of pharmaceutical research and trends in the biopharmaceutical industries covered by AdisInsight.

Preview the report for free now

Drawing from data and intelligence found in our database, our report aims to present an updated overview of drug development over 2022, including: 

  • Top 10 AdisInsight drug profiles viewed
  • Overview of drug launches
  • Summary of drug development programme failures

To access the full report, please submit the form below

Fill in all fields correctly.A technical error occurred.https://www.springernature.com/gp/librarians/landing/access-confirmation

We collect and use your personal data to facilitate your request. We won’t contact you for anything unrelated to this request, neither will we share your information with any third parties, as detailed in our privacy policy. We may share it with our affiliated companies and use it internally for analysis purposes.

Here is what comes ONLY in the full report:

  • Research trends 
  • Outlook on clinical trials
  • New drug profiles released
  • Key deals